Cimetidine is a commonly used H-2-receptor antagonist that has been re
commended for the prevention of acid aspiration syndrome and has been
shown to potentiate vecuronium-induced neuromuscular block. The presen
t study was designed to investigate the influence of a single IV dose
of cimetidine on the neuromuscular effects of rocuronium, an analogue
of vecuronium with a short onset time. Methods. Twenty adults aged 18-
65 years were included in the study with their informed consent and ap
proval of the Ethics Committee. Following oxazepam premedication, 10 p
atients were randomly allocated to receive cimetidine 400 mg IV 30 min
before anaesthesia. After fentanyl and thiopentone induction, single-
twitch stimulation of the ulnar nerve was performed every 10 s. Follow
ing stabilisation of control responses, patients received rocuronium 0
.6 mg/kg for intubation. Anaesthesia was maintained with enflurane les
s than or equal to 0.8 vol.% (end-tidal) and 65% nitrous oxide. Onset
time and recovery times to 25% and 75% of the twitch control values we
re recorded. Results. Onset and recovery times did not differ between
groups. Conclusions. The results of the present study demonstrate that
cimetidine does not increase the duration of rocuronium neuromuscular
blockade. Inhibition of the cytochrome P450 system or a direct effect
at the neuromuscular junction have been suggested as the mechanisms o
f drug interaction associated with cimetidine. Impairment of hepatic m
icrosomal drug metabolism results in a prolonged duration of action of
vecuronium, which appears to be eliminated primarily via the liver. D
ata on the elimination pathway of rocuronium in humans are not availab
le. The fact that cimetidine does not alter the recovery from rocuroni
um-induced neuromuscular block confirms a previous suggestion that roc
uronium may not be eliminated principally by the liver. A direct effec
t of cimetidine on the neuromuscular junction not be confirmed by this
Therefore, cimetidine can be given as premedication without a risk of
prolonged rocuronium block.